STEPHANIE CHLEBUS-NICK: Open Payments
NPI 1518927946 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,311 in 63 payments from 21 companies in 2025. Trend: 2023 $1,580 · 2024 $1,948 · 2025 $1,311
Food & beverage: $1,284Education: $27
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $330 |
| Corcept Therapeutics | 11 | $247 |
| Medtronic, Inc. | 4 | $125 |
| Abbott Laboratories | 5 | $92 |
| Lilly USA, LLC | 4 | $66 |
| Xeris Pharmaceuticals, Inc. | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| Amgen Inc. | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Insulet Corporation | 1 | $38 |
Products named: Korlym, Wegovy, MINIMED 780G, Ozempic, JARDIANCE, FREESTYLE LIBRE 3, MOUNJARO, PROCLAIM.
Industry payments across PA — which companies pay providers there.
